Bluebird
Sell4.97
Spread0.60
Buy5.57

Trade bluebird bio, Inc. - BLUE stock price

Sell4.97
Spread0.60
Buy5.57
1m
5m
15m
30m
1H
4H
1D
1W
History
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. Its product candidates include Lenti-D that is in Phase II/III clinical trials for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder; and LentiGlobin, which is in various clinical studies for the treatment of transfusion- transfusion-dependent ß-thalassemia and severe sickle cell disease. The company's lead product candidates in oncology include bb2121 and bb21217, which are anti- B-cell maturation antigens in Phase I clinical trials for the treatment of relapsed/refractory multiple myeloma. bluebird bio, Inc. has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. It also has collaborations with Medigene AG for the research and development of T cell receptor product candidates directed against antigens for the treatment of cancer indications; and TC BioPharm Limited to research and develop gamma delta chimeric antigen receptor modified T cell product candidates for cancer immunotherapy, as well as a partnership agreement with Celgene European Investment Company LLC. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Articles
Could this be Avalanche’s buy-the-dip moment?
BTC slips as ETH, SOL drive $1.9 billion crypto funds inflows
Ethereum treasury sprint: ETH Strategy raises more than 12k ETH – what happens next?
Crypto for retail and institutions shouldn’t be a double-edged play, but an all-in-one | Opinion
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BLUE price history

Date Close Change Chg% Open Min. Max.
2022-09-30 4.97 0.00 0.00 4.97 4.97 4.97
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks